COVID-19 Research
Identifying potential anti-COVID-19 compounds targeting the RNA dependent RNA polymerases (RdRp) of SARS-CoV-2
A novel vaccine evaluation platform to support SARS-CoV-2 vaccine development in resource-limiting settings
T-cell Immunology of COVID-19 infection and vaccination
Examining potential for the use of plant natural products, flavonoids, against SARS-CoV-2
Testing potential of glucosinolate derived isothiocyanate for antiviral activity against COVID-19
A platform for producing COVID-19 related antigens and antiviral proteins through transient expression in plants
Peptide-based therapeutics using machine learning
Genome sequencing of SARS-CoV-2 from clinical samples
Generation of virus-neutralising human monoclonal antibodies (hmABs) against SARS-CoV-2 as potential therapeutics (CSIR-NMITLI funded project)
A rapid approach to generate immortalised B cells for monoclonal antibody generation from SARS-CoV-2 recovered and vaccinated group
Pages
